However, NOL7 expression showed no significant change during disease progression in several cancers, including cervical squamous cell carcinoma (CESC), PAAD, skin cutaneous melanoma (SKCM), and uterine corpus endometrial carcinoma (UCEC). The gene discussed is NOL7; the disease is uterine corpus endometrial carcinoma.